Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-28 Stonehouse Jon P President & CEO Option exercise +56,949 $3.26 $186K 698,316
2018-02-28 Stonehouse Jon P President & CEO Shares withheld for taxes −43,224 $4.97 $215K 655,092
2018-02-28 Stonehouse Jon P President & CEO Option exercise · Emp. Stock Option (Right to Buy) −56,949 0
2018-02-28 Barnes Alane P VP, General Counsel & Corp Sec Option exercise +6,709 $3.26 $22K 85,768
2018-02-28 Barnes Alane P VP, General Counsel & Corp Sec Option exercise · Emp. Stock Option (Right to Buy) −6,709 0
2018-01-20 Barnes Alane P VP, General Counsel & Corp Sec Shares withheld for taxes −1,961 $5.59 $11K 77,129
2018-01-20 Babu Yarlagadda S Senior VP - Drug Discovery Shares withheld for taxes −3,872 $5.59 $22K 99,996
2018-01-20 Sheridan William P Senior VP - CMO Shares withheld for taxes −4,628 $5.59 $26K 18,058
2018-01-20 STAAB THOMAS R II Senior Vice President and CFO Shares withheld for taxes −3,979 $5.59 $22K 137,383
2018-01-20 Stonehouse Jon P President & CEO Shares withheld for taxes −9,584 $5.59 $54K 638,367

Page 38 of 38 · 750 trades